Literature DB >> 11854897

Liver resection for cancer.

R W Parks1, O J Garden.   

Abstract

Entities:  

Mesh：

Year:  2001        PMID： 11854897      PMCID： PMC4695590          DOI： 10.3748/wjg.v7.i6.766

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  60 in total

1.  Total right hepatic lobectomy for primary hepatoma.

Authors:  T Y LIN; K M CHEN; T K LIU
Journal:  Surgery       Date:  1960-12       Impact factor: 3.982

2.  A study of prognostic factors for hepatic resection for colorectal metastases.

Authors:  M Taylor; J Forster; B Langer; B R Taylor; P D Greig; C Mahut
Journal:  Am J Surg       Date:  1997-06       Impact factor: 2.565

3.  Gallbladder carcinoma discovered during laparoscopic cholecystectomy: aggressive reresection is beneficial.

Authors:  Y Fong; N Heffernan; L H Blumgart
Journal:  Cancer       Date:  1998-08-01       Impact factor: 6.860

4.  Does the subspecialty of the surgeon performing primary colonic resection influence the outcome of patients with hepatic metastases referred for resection?

Authors:  S J Wigmore; K Madhavan; E J Currie; D C Bartolo; O J Garden
Journal:  Ann Surg       Date:  1999-12       Impact factor: 12.969

5.  An analysis of 412 cases of hepatocellular carcinoma at a Western center.

Authors:  Y Fong; R L Sun; W Jarnagin; L H Blumgart
Journal:  Ann Surg       Date:  1999-06       Impact factor: 12.969

6.  Regeneration of the un-embolized liver parenchyma following portal vein embolization.

Authors:  K Yamakado; K Takeda; K Matsumura; A Nakatsuka; T Hirano; N Kato; H Sakuma; T Nakagawa; Y Kawarada
Journal:  J Hepatol       Date:  1997-11       Impact factor: 25.083

7.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

8.  Virtual hepatic resection using three-dimensional reconstruction of helical computed tomography angioportograms.

Authors:  S J Wigmore; D N Redhead; X J Yan; J Casey; K Madhavan; C H Dejong; E J Currie; O J Garden
Journal:  Ann Surg       Date:  2001-02       Impact factor: 12.969

9.  Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.

Authors:  C H Su; S H Tsay; C C Wu; Y M Shyr; K L King; C H Lee; W Y Lui; T J Liu; F K P'eng
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

Review 10.  Neuroendocrine metastases of the liver.

Authors:  I Ihse; B Persson; S Tibblin
Journal:  World J Surg       Date:  1995 Jan-Feb       Impact factor: 3.352
View more
  10 in total

1.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

2.  Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.

Authors:  Wen-He Zhao; Zhi-Min Ma; Xing-Ren Zhou; Yi-Zheng Feng; Bao-Shan Fang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 3.  The prognostic significance of clinical and pathological features in hepatocellular carcinoma.

Authors:  Lun-Xiu Qin; Zhao-You Tang
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Local recurrence is an important prognostic factor of hepatocellular carcinoma.

Authors:  Eiichirou Arimura; Kazuhiro Kotoh; Makoto Nakamuta; Shusuke Morizono; Munechika Enjoji; Hajime Nawata
Journal:  World J Gastroenterol       Date:  2005-09-28       Impact factor: 5.742

Review 5.  Combined interventional therapies of hepatocellular carcinoma.

Authors:  Jun Qian; Gan-Sheng Feng; Thomas Vogl
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

6.  The analysis of gamma-glutamyl transpeptidase gene in different type liver tissues.

Authors:  Guo-Qing Han; Cheng-Yong Qin; Rong-Hua Shu
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

Review 7.  Current treatment for liver metastases from colorectal cancer.

Authors:  Lian-Xin Liu; Wei-Hui Zhang; Hong-Chi Jiang
Journal:  World J Gastroenterol       Date:  2003-02       Impact factor: 5.742

8.  Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.

Authors:  Fu-Hua Yan; Kang-Rong Zhou; Jie-Min Cheng; Jian-Hua Wang; Zhi-Ping Yan; Reng-Rong Da; Jia Fan; Yuan Ji
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

9.  Accuracy of indocyanine green pulse spectrophotometry clearance test for liver function prediction in transplanted patients.

Authors:  Chung-Bao Hsieh; Chung-Jueng Chen; Teng-Wei Chen; Jyh-Cherng Yu; Kuo-Liang Shen; Tzu-Ming Chang; Yao-Chi Liu
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

10.  Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.

Authors:  En-Hua Xiao; Jing-Qing Li; Jie-Fu Huang
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.